시장보고서

상품코드

1611537

Fill-finish 의약품 수탁제조 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 분자별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Fill-finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Vials, Cartridges), By Molecule (Large, Small), By End Use, By Region, And Segment Forecasts, 2025 - 2030

발행일: 2024년 11월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Fill-finish 의약품 수탁제조 시장 성장과 동향

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 Fill-finish 의약품 수탁제조 시장 규모는 2025-2030년에 CAGR 8.3%로 확대하며, 2030년에는 290억 6,000만 달러에 달할 것으로 추정되고 있습니다.

주사제 의약품에 대한 수요 증가는 Fill-finish 의약품 수탁제조 시장의 주요 촉진요인 중 하나입니다. 주사제는 바늘과 주사기 또는 기타 전달 시스템을 사용하여 혈류, 근육 조직 또는 신체의 다른 부위에 직접 전달되는 약물입니다. 이러한 의약품은 암, 자가면역질환, 감염성 질환 등 다양한 질병을 치료하는 데 사용됩니다.

주사제 수요는 최근 몇 가지 요인으로 인해 꾸준히 증가하고 있습니다. 주요 원동력 중 하나는 주사를 통한 장기 치료가 필요한 암, 당뇨병과 같은 만성질환의 유병률 증가입니다. 또한 주사로 투여되는 새로운 생물학적 제제의 개발도 주사제 수요 증가에 기여하고 있습니다.

COVID-19 팬데믹은 시장에 큰 영향을 미쳤습니다. 위탁 생산은 의약품을 바이알, 주사기, 카트리지 및 기타 전달 시스템에 의약품을 채우는 제약 산업에서 필수적인 작업입니다. COVID-19는 전 세계 공급망에 혼란을 일으켜 운영에 필요한 원료 및 기타 핵심 부품의 부족을 초래했습니다. 이로 인해 특히 COVID-19 환자 치료에 사용되는 의약품과 백신 생산에 지연이 발생했습니다.

또한 팬데믹으로 인해 특정 의약품과 백신에 대한 수요가 증가하면서 완제품 위탁 생산 업체들의 생산 능력에 더욱 큰 압박을 가하고 있습니다. 많은 제조업체들은 바이러스 확산을 막기 위해 시행된 사회적 거리두기 지침 및 기타 제한 조치로 인해 생산 능력을 축소해야 하는 상황에 처해 있습니다.

필수품 의약품 수탁제조 시장 보고서 하이라이트

미충족 의료 수요에 대한 대응 가능성이 높아짐에 따라 2024년 매출 비중은 거대 분자가 67.3%로 가장 큰 비중을 차지할 것으로 예상됩니다.
바이알 부문은 바이알 충전 장비의 기술 발전으로 인해 2024년 53.4%의 가장 높은 매출 점유율을 차지할 것입니다.
바이오 제약 기업 부문은 2024년 55.3%의 가장 높은 매출 점유율을 차지할 것으로 예상되며, 의약품 및 백신 개발 증가가 시장 성장의 주요 요인으로 작용할 것으로 보입니다.
지역별로는 북미 Fill-finish 의약품 수탁제조 시장이 2024년 매출 점유율 34.9%로 세계 시장을 장악했습니다.

지역별 시장 점유율 분석, 2024년과 2030년
지역별 시장 대시보드
시장 규모, 예측 동향 분석, 2018-2030년
북미
- 국가별, 2018-2030년
- 미국
- 캐나다
- 멕시코
유럽
- 국가별, 2018-2030년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 덴마크
- 스웨덴
아시아태평양
- 국가별, 2018-2030년
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 국가별, 2018-2030년
- 브라질
- 아르헨티나
중동 및 아프리카
- 국가별, 2018-2030년
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

참가자 개요
기업의 시장 현황 분석
기업 분류
전략 지도제작
기업 개요/상장기업
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Boehringer Ingelheim International GmbH
- Catalent, Inc(acquired by Novo Holdings A/S)
- Societal CDMO(Recro Pharma, Inc)
- Baxter
- Eurofins Scientific
- Symbiosis Pharmaceutical Services Ltd
- MabPlex International Co. Ltd.
- Recipharm AB
- Fresenius Kabi, USA LLC
- Lonza

KSA 25.01.03

Fill-Finish Pharmaceutical Contract Manufacturing Market Growth & Trends:

The global fill-finish pharmaceutical contract manufacturing market size is estimated to reach USD 29.06 billion by 2030, expanding at a CAGR of 8.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for injectable drugs is one of the primary drivers of the fill-finish pharmaceutical contract manufacturing market. Injectable drugs are medications that are delivered directly into the bloodstream, muscle tissue, or other parts of the body using a needle and syringe or other delivery system. These drugs are used to treat a wide range of conditions, including cancer, autoimmune disorders, and infectious diseases, among others.

The demand for injectable drugs has been growing steadily in recent years due to several factors. One of the key drivers is the increasing prevalence of chronic diseases such as cancer and diabetes, which require long-term treatment with injectable medications. Additionally, the development of new biologic drugs, which are often administered via injection, has also contributed to the growing demand for injectable drugs.

The COVID-19 pandemic has had a significant impact on the market. Fill-finish contract manufacturing is an essential part of the pharmaceutical industry, which involves the filling and finishing of drug products into vials, syringes, cartridges, and other delivery systems. The pandemic caused disruptions in the global supply chain, resulting in shortages of raw materials and other critical components required for operations. This has led to delays in the production of drugs and vaccines, particularly those used in the treatment of COVID-19 patients.

Moreover, the pandemic has also caused an increase in demand for certain drugs and vaccines, further straining the capacity of fill-finish contract manufacturers. Many manufacturers have been forced to operate at reduced capacity due to social distancing guidelines and other restrictions imposed to control the spread of the virus.

Fill-Finish pharmaceutical Contract Manufacturing Market Report Highlights:

The large molecules segment accounted for the largest revenue share of 67.3% in 2024 due to the rising potential to treat unmet medical needs.
The vials segment is accounted for the highest revenue share of 53.4% in 2024 due to increasing technological advancements in vial filling equipment.
The biopharmaceutical companies segment accounted for the highest revenue share of 55.3% in 2024, an increase in the development of drugs and vaccines is the key factor for the growth of the market.
By region, North America fill-finish pharmaceutical contract manufacturing market dominated the global market with a revenue share of 34.9% in 2024.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Molecule
- 1.2.3. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Fill-finish Pharmaceutical Contract Manufacturing Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrants
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Fill-finish Pharmaceutical Contract Manufacturing Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Prefilled Syringes
- 4.4.1. Prefilled Syringes Market, 2018 - 2030 (USD Million)
4.5. Vials
- 4.5.1. Vials Market, 2018 - 2030 (USD Million)
4.6. Cartridges
- 4.6.1. Cartridges Market, 2018 - 2030 (USD Million)
4.7. Others
- 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Fill-finish Pharmaceutical Contract Manufacturing Market: Molecule Business Analysis

5.1. Molecule Market Share, 2024 & 2030
5.2. Molecule Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Molecule, 2018 to 2030 (USD Million)
5.4. Large Molecules
- 5.4.1. Large Molecules Market, 2018 - 2030 (USD Million)
5.5. Small Molecules
- 5.5.1. Small Molecules Market, 2018 - 2030 (USD Million)

Chapter 6. Fill-finish Pharmaceutical Contract Manufacturing Market: End Use Business Analysis

6.1. End Use Market Share, 2024 & 2030
6.2. End Use Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Biopharmaceutical Companies
- 6.4.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
6.5. Pharmaceutical Companies
- 6.5.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)

Chapter 7. Fill-finish Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis by Product, Molecule, and End Use

7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
- 7.4.1. North America Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
  - 7.4.2.1. Key Country Dynamics
  - 7.4.2.2. Regulatory Framework
  - 7.4.2.3. Competitive Insights
  - 7.4.2.4. U.S. Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
  - 7.4.3.1. Key Country Dynamics
  - 7.4.3.2. Regulatory Framework
  - 7.4.3.3. Competitive Insights
  - 7.4.3.4. Canada Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
  - 7.4.4.1. Key Country Dynamics
  - 7.4.4.2. Regulatory Framework
  - 7.4.4.3. Competitive Insights
  - 7.4.4.4. Mexico Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
- 7.5.1. Europe Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key Country Dynamics
  - 7.5.2.2. Regulatory Framework
  - 7.5.2.3. Competitive Insights
  - 7.5.2.4. UK Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Germany
  - 7.5.3.1. Key Country Dynamics
  - 7.5.3.2. Regulatory Framework
  - 7.5.3.3. Competitive Insights
  - 7.5.3.4. Germany Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key Country Dynamics
  - 7.5.4.2. Regulatory Framework
  - 7.5.4.3. Competitive Insights
  - 7.5.4.4. France Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key Country Dynamics
  - 7.5.5.2. Regulatory Framework
  - 7.5.5.3. Competitive Insights
  - 7.5.5.4. Italy Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
  - 7.5.6.1. Key Country Dynamics
  - 7.5.6.2. Regulatory Framework
  - 7.5.6.3. Competitive Insights
  - 7.5.6.4. Spain Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Norway
  - 7.5.7.1. Key Country Dynamics
  - 7.5.7.2. Regulatory Framework
  - 7.5.7.3. Competitive Insights
  - 7.5.7.4. Norway Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Denmark
  - 7.5.8.1. Key Country Dynamics
  - 7.5.8.2. Regulatory Framework
  - 7.5.8.3. Competitive Insights
  - 7.5.8.4. Denmark Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Sweden
  - 7.5.9.1. Key Country Dynamics
  - 7.5.9.2. Regulatory Framework
  - 7.5.9.3. Competitive Insights
  - 7.5.9.4. Sweden Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. Asia Pacific Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.6.2. Japan
  - 7.6.2.1. Key Country Dynamics
  - 7.6.2.2. Regulatory Framework
  - 7.6.2.3. Competitive Insights
  - 7.6.2.4. Japan Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
  - 7.6.3.1. Key Country Dynamics
  - 7.6.3.2. Regulatory Framework
  - 7.6.3.3. Competitive Insights
  - 7.6.3.4. China Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
  - 7.6.4.1. Key Country Dynamics
  - 7.6.4.2. Regulatory Framework
  - 7.6.4.3. Competitive Insights
  - 7.6.4.4. India Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. South Korea
  - 7.6.5.1. Key Country Dynamics
  - 7.6.5.2. Regulatory Framework
  - 7.6.5.3. Competitive Insights
  - 7.6.5.4. South Korea Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Australia
  - 7.6.6.1. Key Country Dynamics
  - 7.6.6.2. Regulatory Framework
  - 7.6.6.3. Competitive Insights
  - 7.6.6.4. Australia Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
  - 7.6.7.1. Key Country Dynamics
  - 7.6.7.2. Regulatory Framework
  - 7.6.7.3. Competitive Insights
  - 7.6.7.4. Thailand Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
- 7.7.1. Latin America Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
  - 7.7.2.1. Key Country Dynamics
  - 7.7.2.2. Regulatory Framework
  - 7.7.2.3. Competitive Insights
  - 7.7.2.4. Brazil Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
  - 7.7.3.1. Key Country Dynamics
  - 7.7.3.2. Regulatory Framework
  - 7.7.3.3. Competitive Insights
  - 7.7.3.4. Argentina Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.8. MEA
- 7.8.1. MEA Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
  - 7.8.2.1. Key Country Dynamics
  - 7.8.2.2. Regulatory Framework
  - 7.8.2.3. Competitive Insights
  - 7.8.2.4. South Africa Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
  - 7.8.3.1. Key Country Dynamics
  - 7.8.3.2. Regulatory Framework
  - 7.8.3.3. Competitive Insights
  - 7.8.3.4. Saudi Arabia Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
  - 7.8.4.1. Key Country Dynamics
  - 7.8.4.2. Regulatory Framework
  - 7.8.4.3. Competitive Insights
  - 7.8.4.4. UAE Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
  - 7.8.5.1. Key Country Dynamics
  - 7.8.5.2. Regulatory Framework
  - 7.8.5.3. Competitive Insights
  - 7.8.5.4. Kuwait Fill-finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
- 8.5.1. Thermo Fisher Scientific Inc.
  - 8.5.1.1. Overview
  - 8.5.1.2. Financial Performance
  - 8.5.1.3. Product Benchmarking
  - 8.5.1.4. Strategic Initiatives
- 8.5.2. Sartorius AG
  - 8.5.2.1. Overview
  - 8.5.2.2. Financial Performance
  - 8.5.2.3. Product Benchmarking
  - 8.5.2.4. Strategic Initiatives
- 8.5.3. Boehringer Ingelheim International GmbH
  - 8.5.3.1. Overview
  - 8.5.3.2. Financial Performance
  - 8.5.3.3. Product Benchmarking
  - 8.5.3.4. Strategic Initiatives
- 8.5.4. Catalent, Inc (acquired by Novo Holdings A/S)
  - 8.5.4.1. Overview
  - 8.5.4.2. Financial Performance
  - 8.5.4.3. Product Benchmarking
  - 8.5.4.4. Strategic Initiatives
- 8.5.5. Societal CDMO (Recro Pharma, Inc)
  - 8.5.5.1. Overview
  - 8.5.5.2. Financial Performance
  - 8.5.5.3. Product Benchmarking
  - 8.5.5.4. Strategic Initiatives
- 8.5.6. Baxter
  - 8.5.6.1. Overview
  - 8.5.6.2. Financial Performance
  - 8.5.6.3. Product Benchmarking
  - 8.5.6.4. Strategic Initiatives
- 8.5.7. Eurofins Scientific
  - 8.5.7.1. Overview
  - 8.5.7.2. Financial Performance
  - 8.5.7.3. Product Benchmarking
  - 8.5.7.4. Strategic Initiatives
- 8.5.8. Symbiosis Pharmaceutical Services Ltd
  - 8.5.8.1. Overview
  - 8.5.8.2. Financial Performance
  - 8.5.8.3. Product Benchmarking
  - 8.5.8.4. Strategic Initiatives
- 8.5.9. MabPlex International Co. Ltd.
  - 8.5.9.1. Overview
  - 8.5.9.2. Financial Performance
  - 8.5.9.3. Product Benchmarking
  - 8.5.9.4. Strategic Initiatives
- 8.5.10. Recipharm AB
  - 8.5.10.1. Overview
  - 8.5.10.2. Financial Performance
  - 8.5.10.3. Product Benchmarking
  - 8.5.10.4. Strategic Initiatives
- 8.5.11. Fresenius Kabi, USA LLC
  - 8.5.11.1. Overview
  - 8.5.11.2. Financial Performance
  - 8.5.11.3. Product Benchmarking
  - 8.5.11.4. Strategic Initiatives
- 8.5.12. Lonza
  - 8.5.12.1. Overview
  - 8.5.12.2. Financial Performance
  - 8.5.12.3. Product Benchmarking
  - 8.5.12.4. Strategic Initiatives

Fill-finish 의약품 수탁제조 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 분자별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Fill-finish Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Prefilled Syringes, Vials, Cartridges), By Molecule (Large, Small), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Fill-finish 의약품 수탁제조 시장 성장과 동향

필수품 의약품 수탁제조 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 개요

제3장 Fill-finish 의약품 계약 제조 시장 변수, 동향, 범위

제4장 Fill-finish 의약품 수탁제조 시장 : 제품 비즈니스 분석

제5장 Fill-finish 의약품 수탁제조 시장 : 분자 비즈니스 분석

제6장 Fill-finish 의약품 수탁제조 시장 : 최종 용도 비즈니스 분석

제7장 Fill-finish 의약품 수탁제조 시장 : 제품, 분자, 최종 용도에 의한 지역별, 추정·동향 분석